Cash Flow Statement
Growth Metrics

Harvard Bioscience (HBIO) Free Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 73.89%
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 271.70%
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -6.70%
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 9.81%
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 56.82%
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 339.10%
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 124.13%
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 105.94%
10 Harvard Bioscience 25.38 Mn 18.29 Mn 12.24 Mn -144.00%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -144.00%
Dec 31, 2025 -138.27%
Sep 30, 2025 150.93%
Jun 30, 2025 260.22%
Mar 31, 2025 226.25%
Dec 31, 2024 -59.00%
Sep 30, 2024 -141.55%
Jun 30, 2024 -154.83%
Mar 31, 2024 -52.27%
Dec 31, 2023 42.10%
Sep 30, 2023 1,901.93%
Jun 30, 2023 580.22%
Mar 31, 2023 164.63%
Dec 31, 2022 1,114.11%
Sep 30, 2022 118.16%
Jun 30, 2022 -212.46%
Mar 31, 2022 -377.31%
Dec 31, 2021 -109.93%
Sep 30, 2021 -210.36%
Jun 30, 2021 -73.11%
Mar 31, 2021 -66.31%
Dec 31, 2020 36.14%
Sep 30, 2020 -63.15%
Jun 30, 2020 454.38%
Mar 31, 2020 40.87%
Dec 31, 2019 -28.66%
Sep 30, 2019 265.76%
Jun 30, 2019 -66.81%
Mar 31, 2019 4,248.89%
Dec 31, 2018 316.84%
Sep 30, 2018 -189.42%
Jun 30, 2018 381.36%
Mar 31, 2018 94.43%
Dec 31, 2017 -128.15%
Sep 30, 2017 -10.72%
Jun 30, 2017 -84.72%
Mar 31, 2017 12.84%
Dec 31, 2016 -41.73%
Sep 30, 2016 387.77%
Jun 30, 2016 148.77%
Mar 31, 2016 -269.47%
Dec 31, 2015 243.54%
Sep 30, 2015 -168.02%
Jun 30, 2015 -268.87%
Mar 31, 2015 -59.60%
Dec 31, 2014 14.70%
Sep 30, 2014 -44.08%
Jun 30, 2014 81.26%
Mar 31, 2014 45.59%
Dec 31, 2013 -11.96%
Sep 30, 2013 -36.43%
Jun 30, 2013 -63.82%
Mar 31, 2013 -51.10%
Dec 31, 2012 -32.47%
Sep 30, 2012 103.48%
Jun 30, 2012 38.01%
Mar 31, 2012 19.77%
Dec 31, 2011 -33.07%
Sep 30, 2011 -26.52%